Activation of the mucosal immune system in irritable bowel syndrome.

By V. Chadwick, Wangxue Chen, D. Shu, Barbara C Paulus, P. Bethwaite, A. Tie, I. Wilson. Gastroenterology, 2002

846 citations recorded by the source corpus.

Subfields: Epidemiology, Gastroenterology, Genetics

View Paper: https://www.semanticscholar.org/paper/3395b687aa5cfbe083071016a4376de4baaca872

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Gastroenterology

1. J. Cryan
2. Ted G. Dinan
3. G. Clarke
4. M. Simrén
5. S. Grenham
6. E. Quigley
7. P. Kennedy
8. J. Foster

In Genetics

1. J. Cryan
2. Ted G. Dinan
3. S. Grenham
4. G. Clarke

Citations in the corpus

• Efficacy of an Encapsulated Probiotic Bifidobacterium infantis 35624 in Women with Irritable Bowel Syndrome (2006, background): “Up to 25% of patients date the onset of their problem from a gastrointestinal infection (8), and evidence accumulates to indicate the presence of an inflammatory response in the gastrointestinal mucosa in IBS (9–12).”
• Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions (2010, background): “Increased numbers of mucosal mast cells have not, however, been shown consistently in all studies”
• Brain–Gut–Microbe Communication in Health and Disease (2011, background): “IBS patients with normal histology had increased intraepithelial lymphocytes and CD3+ and CD25+ cells in the lamina propria (Chadwick et al., 2002).”